相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Neoantigen cancer vaccine augments anti-CTLA-4 efficacy
Erika Salvatori et al.
NPJ VACCINES (2022)
A Virus-Mimicking Nucleic Acid Nanogel Reprograms Microglia and Macrophages for Glioblastoma Therapy
Xihui Gao et al.
ADVANCED MATERIALS (2021)
Characterization and Specification of a Trivalent Protein-Based Pneumococcal Vaccine Formulation Using an Adjuvant-Free Nanogel Nasal Delivery System
Yoshikazu Yuki et al.
MOLECULAR PHARMACEUTICS (2021)
Intracellular signaling pathway in dendritic cells and antigen transport pathway in vivo mediated by an OVA@DDAB/PLGA nano-vaccine
Shulan Han et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Ignacio Melero et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci
Rika Nakahashi-Ouchida et al.
VACCINE (2021)
PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy
Julia Koerner et al.
NATURE COMMUNICATIONS (2021)
Nanogels: An overview of properties, biomedical applications, future research trends and developments
E. S. Anooj et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
Squaric Ester-Based, pH-Degradable Nanogels: Modular Nanocarriers for Safe, Systemic Administration of Toll-like Receptor 7/8 Agonistic Immune Modulators
Anne Huppertsberg et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Multifunctional Traceable Liposomes with Temperature-Triggered Drug Release and Neovasculature-Targeting Properties for Improved Cancer Chemotherapy
Eiji Yuba et al.
MOLECULAR PHARMACEUTICS (2021)
Reduction-Sensitive Protein Nanogels Enhance Uptake of Model and Tumor Lysate Antigens In Vitro by Mouse- and Human-Derived Dendritic Cells
Cristiana Berti et al.
ACS APPLIED BIO MATERIALS (2021)
Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice
Sharmilla Devi Jayasingam et al.
FRONTIERS IN ONCOLOGY (2020)
Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses
Dorian A. Stolk et al.
FRONTIERS IN IMMUNOLOGY (2020)
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
Michael Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dawn of lipid nanoparticles in lymph node targeting: Potential in cancer immunotherapy
Takashi Nakamura et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Ugur Sahin et al.
NATURE (2020)
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Synergistic anti-tumor efficacy by combination therapy of a self-assembled nanogel vaccine with an immune checkpoint anti-PD-1 antibody
Risako Miura et al.
RSC ADVANCES (2020)
Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance
Daisuke Muraoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Nanogels and Microgels: From Model Colloids to Applications, Recent Developments, and Future Trends
Matthias Karg et al.
LANGMUIR (2019)
Material design for lymph node drug delivery
Alex Schudel et al.
NATURE REVIEWS MATERIALS (2019)
Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers
F. Zhang et al.
NATURE COMMUNICATIONS (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Improving cancer immunotherapy through nanotechnology
Michael S. Goldberg
NATURE REVIEWS CANCER (2019)
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
S. K. Daniel et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2019)
Targeting Protumoral Tumor-Associated Macrophages with Nanobody-Functionalized Nanogels through Strain Promoted Azide Alkyne Cycloaddition Ligation
Lutz Nuhn et al.
BIOCONJUGATE CHEMISTRY (2018)
Metabolic Barriers to T Cell Function in Tumors
Ayaka Sugiura et al.
JOURNAL OF IMMUNOLOGY (2018)
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Li Tang et al.
NATURE BIOTECHNOLOGY (2018)
CANCER Re-educating tumour-associated macrophages with nanoparticles
Megan Cully
NATURE REVIEWS DRUG DISCOVERY (2018)
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth
Ilenia Pacella et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
Christopher B. Rodell et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Nanovaccine Incorporated with Hydroxychloroquine Enhances Antigen Cross-Presentation and Promotes Antitumor Immune Responses
Jiale Liu et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei et al.
CANCER DISCOVERY (2018)
Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens
Jie Gao et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Lymph node targeting strategies to improve vaccination efficacy
Hao Jiang et al.
JOURNAL OF CONTROLLED RELEASE (2017)
De-novo and acquired resistance to immune checkpoint targeting
Nicholas L. Syn et al.
LANCET ONCOLOGY (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Macrophage Death following Influenza Vaccination Initiates the Inflammatory Response that Promotes Dendritic Cell Function in the Draining Lymph Node
Nikolaos Chatziandreou et al.
CELL REPORTS (2017)
Oncolytic virus therapy: A new era of cancer treatment at dawn
Hiroshi Fukuhara et al.
CANCER SCIENCE (2016)
Beyond antigens and adjuvants: formulating future vaccines
Tyson J. Moyer et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation
Kruti S. Soni et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Delivery of siRNAs to Dendritic Cells Using DEC205-Targeted Lipid Nanoparticles to Inhibit Immune Responses
Joseph A. Katakowski et al.
MOLECULAR THERAPY (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Maturation of dendritic cells by pullulan promotes anti-cancer effect
Wei Zhang et al.
ONCOTARGET (2016)
PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity
A. L. Silva et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Current advances in self-assembled nanogel delivery systems for immunotherapy
Yoshiro Tahara et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Nanocarrier-Integrated Microspheres: Nanogel Tectonic Engineering for Advanced Drug-Delivery Systems
Yoshiro Tahara et al.
ADVANCED MATERIALS (2015)
Lymphatic-targeted cationic liposomes: A robust vaccine adjuvant for promoting long-term immunological memory
Ce Wang et al.
JOURNAL OF CONTROLLED RELEASE (2015)
In situ Delivery of Antigen to DC-SIGN+D14+ Dermal Dendritic Cells Results in Enhanced CD8+ T-Cell Responses
Cynthia M. Fehres et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques
Y. Fukuyama et al.
MUCOSAL IMMUNOLOGY (2015)
Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses
Jun Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Overcoming T cell exhaustion in infection and cancer
Kristen E. Pauken et al.
TRENDS IN IMMUNOLOGY (2015)
Nanogel-Based Immunologically Stealth Vaccine Targets Macrophages in the Medulla of Lymph Node and Induces Potent Antitumor Immunity
Daisuke Muraoka et al.
ACS NANO (2014)
Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response
Susan N. Thomas et al.
BIOMATERIALS (2014)
Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: A comparative study
Luis J. Cruz et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Different Antigen-Processing Activities in Dendritic Cells, Macrophages, and Monocytes Lead to Uneven Production of HIV Epitopes and Affect CTL Recognition
Jens Dinter et al.
JOURNAL OF IMMUNOLOGY (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist
Kouji Kobiyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Molecular mechanisms that influence the macrophage M1-M2 polarization balance
Nan Wang et al.
FRONTIERS IN IMMUNOLOGY (2014)
Depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomas
Jason M. Fritz et al.
FRONTIERS IN IMMUNOLOGY (2014)
Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
Paul Sabbatini et al.
CLINICAL CANCER RESEARCH (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Kaori Sakuishi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines
Tomonori Nochi et al.
NATURE MATERIALS (2010)
The binding of pullulan modified cholesteryl nanogels to Aβ oligomers and their suppression of cytotoxicity
Sebastien Boridy et al.
BIOMATERIALS (2009)
Raspberry-like assembly of cross-linked nanogels for protein delivery
Urara Hasegawa et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Tumor Regulatory T Cells Potently Abrogate Antitumor Immunity
Zuqiang Liu et al.
JOURNAL OF IMMUNOLOGY (2009)
Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel
Shinichi Kageyama et al.
CANCER SCIENCE (2008)
Nanoparticles target distinct dendritic cell populations according to their size
Vania Manolova et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma
Nathan R. Miselis et al.
MOLECULAR CANCER THERAPEUTICS (2008)
HER2-specificT-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan
Shigehisa Kitano et al.
CLINICAL CANCER RESEARCH (2006)
Clodronate-liposome-mediated depletion of tumour-associated macrophages:: a new and highly effective antiangiogenic therapy approach
S. M. Zeisberger et al.
BRITISH JOURNAL OF CANCER (2006)
Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators
A Ben-Baruch
SEMINARS IN CANCER BIOLOGY (2006)
Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy
Y Ikuta et al.
BLOOD (2002)
Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases
A Wollenberg et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Immune responses to tumour antigens:: implications for antigen specific immunotherapy of cancer
D Jäger et al.
JOURNAL OF CLINICAL PATHOLOGY (2001)